Czech Registry of Monoclonal Gammopathies - Technical Solution, Data Collection and Visualisation
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
|September 15, 2017
Summary
The Registry of Monoclonal Gammopathies (RMG) now uses the CLADE-IS platform for efficient data collection and visualization. This enables population-level monitoring of monoclonal gammopathies like multiple myeloma.
Area of Science:
- Hematology
- Medical Informatics
Background:
- Established in 2007 by the Czech Myeloma Group, the Registry of Monoclonal Gammopathies (RMG) collects clinical data on diagnosis, treatment, and survival.
- The registry focuses on monoclonal gammopathies including monoclonal gammopathy of undetermined significance (MGUS), Waldenström macroglobulinaemia (WM), multiple myeloma (MM), and primary AL amyloidosis.
Purpose of the Study:
- To describe the technology for data collection, storage, and online visualization within the RMG.
- To introduce the CLADE-IS platform as a new system for managing registry data and improving data entry accuracy.
Main Methods:
- The CLADE-IS platform was implemented for data collection and storage.
- System functions were designed to streamline data entry and minimize errors for all diagnoses.
- Online data visualization tools were developed for public and authenticated access.
Main Results:
- The RMG currently holds over 8,000 records from 19 Czech and 4 Slovak centers.
- The CLADE-IS platform facilitates efficient data management and error reduction.
- Publicly accessible online visualizations of patient data are now available.
Conclusions:
- The RMG provides a crucial data foundation for population-level disease monitoring.
- The implementation of CLADE-IS enhances the registry's capabilities for managing and visualizing monoclonal gammopathy data.


